- Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia2000 | Second Faculty of Medicine
- Detection of Minimal Residual Disease in Ewing's sarcoma Using RT-PCR2000 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Minimal residual disease is the most important prognostic factor in childhood acute lymphoblastic leukemia2007 | Second Faculty of Medicine
- Aetiology of childhood ALL and AML, molecular genetics and minimal residual disease2015 | Second Faculty of Medicine
- Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine2022 | Publication without faculty affiliation
- Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients2021 | First Faculty of Medicine, Second Faculty of Medicine
- Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients2021 | Second Faculty of Medicine, Central Library of Charles University
- Molecular monitoring of residual disease in chronic lymphocytic leukemiaPublication without faculty affiliation
- Minimal residual disease in chronic lymphocytic leukemia: Detection methods and clinical significance2010 | Third Faculty of Medicine
- Minimal residual disease – detection possibilities in haematological and non-haematological malignancies2013 | Second Faculty of Medicine
- Whole Exome Sequencing of Aberrant Plasma Cells in a Patient with Multiple Myeloma Minimal Residual Disease2017 | Publication without faculty affiliation
- Detection and ex-vivo elimination of residual Ewing sarcoma cells persisting in autologous hematopoietic stem cell graftsPublication without faculty affiliation
- B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL2008 | Second Faculty of Medicine
- Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoring in children with acute lymphoblastic leukaemia?2004 | Second Faculty of Medicine
- A method to identify new molecular markers for assessing minimal residual disease in acute leukemia patients2013 | First Faculty of Medicine, Third Faculty of Medicine
- Laboratory testing for the presence of minimal residual disease using DNA-based RQ-PCR for clonal rearrangements of Ig/TCR defined by PCR or massive parallel sequencing (NGS)Publication without faculty affiliation
- Identification of new molecular markers for minimal residual disease assessment in acute leukemia patients2013 | First Faculty of Medicine, Third Faculty of Medicine
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | Second Faculty of Medicine
- Minimal Residual Disease in Breast Cancer2002 | First Faculty of Medicine
- Detectgion of minimal residual disease in acute lymphoblastic leukemia using quantification of immunoglobulin and T-cell receptor genes rearrangements. How to avoid misinterpretation of the results2005 | Second Faculty of Medicine
- Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant2022 | First Faculty of Medicine, Second Faculty of Medicine
- Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol2021 | Second Faculty of Medicine
- Minimal residual disease in acute myeloid leukemia in children - standardization and evaluation of immunophenotyping in the AML-BFM-98 study2002 | Second Faculty of Medicine
- IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?2018 | Faculty of Medicine in Hradec Králové
- Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection2017 | Second Faculty of Medicine
- Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma2018 | First Faculty of Medicine, Second Faculty of Medicine
- Methods for minimal residual disease detection - new algorithms2003 | Second Faculty of Medicine, Central Library of Charles University
- Detection of minimal residual disease in children - sense and aims2001 | Second Faculty of Medicine, Central Library of Charles University
- Detection of minimal residual disease - comparison of three methods2001 | Central Library of Charles University
- Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study2022 | Second Faculty of Medicine